@hoabaovu21792: Giúp em trả lời những câu hỏi?? #hoabaovurosee #roseevietnam #sonkemlikhangnuoc

Hoa Bảo Vũ Comestic
Hoa Bảo Vũ Comestic
Open In TikTok:
Region: VN
Tuesday 18 November 2025 10:45:23 GMT
7103
1060
9
45

Music

Download

Comments

oanh.v.yu5
chị Oanh yêu ♥️🌹 :
🥰🥰🥰
2025-11-20 09:02:41
0
my.life22607
🧒John Nguyen😎 :
💐❤️
2025-11-20 05:46:22
0
damminh_1991
Hair Đàm Minh :
🤣🤣🤣🤣🤣🤣🤣
2025-11-19 05:13:27
0
oscar771119
奧斯卡 :
🥰🥰🥰
2025-11-18 18:01:13
0
anhtuan96340
Tuấn anh :
😘😘😘
2025-11-18 17:35:05
0
xuancodonkocoai
Đào thế Xuân cô đơn 8386 :
😘❤️🌹
2025-11-18 15:46:28
0
user19479223
user194792 :
😋😋😋
2025-11-18 15:01:44
0
samsul.islam6297
Samsul Islam :
❤️🇧🇩❤️
2025-11-18 13:48:47
0
minhha612
💝 Minh Hà 💝 :
😘😘😘
2025-11-18 11:46:39
0
To see more videos from user @hoabaovu21792, please go to the Tikwm homepage.

Other Videos

“Oprah Winfrey’s back, and she wants to talk about losing weight. Again. On Monday, Oprah’s ABC special, ‘Shame, Blame and the Weight Loss Revolution,’ promised to answer some of the biggest questions around the new weight-loss drugs. The special was, as we call it in academia, a rich text. There were layers of history, with both Oprah and the intellectual history of bodies in pop culture. But, viewed at a distance and as a whole, the one-hour program was above all a harbinger of how the weight-loss industry is rebranding: Obesity is a disease, and — for the first time — it’s not your fault. From the special’s outset, Oprah made the story about GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro — a retelling of her own struggle with weight. Of course, the public noticed last year when a remarkably thin Oprah emerged on red carpets. There was rampant speculation that she was on Ozempic. While Oprah never names which brand of GLP-1 she is taking, she confirmed again in this show that she is on a weight-loss drug. That’s Oprah’s trademark: turning big political questions into a personal narrative of freedom and triumph. And it is this special’s raison d’être. Over and over again, deft production turns the thorny issue of weight-loss medicalization into (admittedly compelling) personal stories. But personal stories about prom dresses and self-esteem distract viewers from the inequality of obesity treatments that risk becoming luxury cosmeceuticals,” says @nytopinion columnist @Tressie McMillan Cottom. #weightloss #oprah #bodypositivity #nytopinion
“Oprah Winfrey’s back, and she wants to talk about losing weight. Again. On Monday, Oprah’s ABC special, ‘Shame, Blame and the Weight Loss Revolution,’ promised to answer some of the biggest questions around the new weight-loss drugs. The special was, as we call it in academia, a rich text. There were layers of history, with both Oprah and the intellectual history of bodies in pop culture. But, viewed at a distance and as a whole, the one-hour program was above all a harbinger of how the weight-loss industry is rebranding: Obesity is a disease, and — for the first time — it’s not your fault. From the special’s outset, Oprah made the story about GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro — a retelling of her own struggle with weight. Of course, the public noticed last year when a remarkably thin Oprah emerged on red carpets. There was rampant speculation that she was on Ozempic. While Oprah never names which brand of GLP-1 she is taking, she confirmed again in this show that she is on a weight-loss drug. That’s Oprah’s trademark: turning big political questions into a personal narrative of freedom and triumph. And it is this special’s raison d’être. Over and over again, deft production turns the thorny issue of weight-loss medicalization into (admittedly compelling) personal stories. But personal stories about prom dresses and self-esteem distract viewers from the inequality of obesity treatments that risk becoming luxury cosmeceuticals,” says @nytopinion columnist @Tressie McMillan Cottom. #weightloss #oprah #bodypositivity #nytopinion

About